DOI:
10.1039/C4RA04486J
(Communication)
RSC Adv., 2014,
4, 29340-29343
A dioxadithiaazacrown ether–BODIPY dyad Hg2+ complex for detection of L-cysteine: fluorescence switching and application to soft material†
Received
13th May 2014
, Accepted 23rd June 2014
First published on 24th June 2014
Abstract
A Hg2+ coordinate complex of a 1,4-dioxa-7,13-dithia-10-azacyclopentadecane–BODIPY dyad 1 recognises L-cysteine (cys), selectively, over other amino acids via reversible complexation/decomplexation and show switching of fluorescence upon sequential addition of Hg2+ and cys solutions. Further, addition of the dyad to the Hg2+ cholate hydrogel is attended by a gel to sol phase transition.
The mercapto biomolecules play a crucial role in important chemical and physiological processes in organisms.1 Among these, L-cysteine (cys) plays a crucial role in plasma. The abnormal levels of cys result in many disorders linked to liver damage, slow growth in children, skin lesions etc.1a,2 Consequently, for prevention of such diseases, many research groups have focussed their attention on the development of probes for the detection of mercapto biomolecules.3 Over the traditional methods, like gas chromatography,4 electrochemical methods,5 mass spectrometry,6 the fluorescence probes are widely being used to recognise the mercapto biomolecules because of the simplicity, high sensitivity and selectivity.3 However, among these, the reversible probes may have edge over the irreversible counterparts as the possible retention of the latter in the cells could cause damage to the cells, thus affecting the further studies.7 Thus, development of reversible fluorescent probes that could avoid toxic cellular retention for the detection of mercapto biomolecules is highly desired. Most of the sensing protocols for thiols have been executed (i) through covalent interactions between the receptor and the analyte such as Michael addition,8 cyclisation with aldehyde9 or cleavage reactions promoted by the thiols.10 The changes are manifested in terms of the changes in photo-physical properties of the receptor, (ii) non-covalent interaction between the receptor and the analyte (chemosensing ensemble),11 where the fluorescent indicator is displaced by the analyte, and (iii) using the redox chemistry of thiol, involving absorption studies.12 Since our research group is involved in development of chemosensors/chemodosimeters for different analytes,13 in one of our recent works,13e a molecular probe 1 (Scheme 1) derived by conjugating the metal ion binding crown ether with the fluorescent signalling handle, BODIPY, for the detection of Pd2+ ions, we noticed that the turn-off fluorescence of 1 resulting from photoinduced electron transfer (PET) was turned-on in the presence of Hg2+ ions as a result of restricted PET. The sensing protocol reverses in the presence of cys, evidently as a consequence of sequestering of Hg2+ by cys from 1, as depicted in Scheme 1. To capitalize on this observation, we planned to develop 1:Hg2+ complex 2, formed in situ, as a fluorescent sensing probe, which could exhibit selectivity and sensitivity to mercapto biomolecules via a reversible decomplexation/complexation mechanism. This is one of the examples14 where such an approach is employed for the detection of a mercapto biomolecule. Additionally, we have explored the possibility of exploiting the changes in the fluorescence of 1 upon addition of Hg2+ and/or cys for fabricating INHIBIT logic gate. Further, we also demonstrate application of 1 for selective determination of toxic Hg2+ in the soft materials.
 |
| Scheme 1 Reversible fluorescence changes in 1 upon addition of Hg2+ and cys. | |
The dyad 1 was synthesised following the route already described and was satisfactorily characterised using spectroscopic data.13e The fluorescence spectrum of 1 (5 × 10−6 M, in CH3CN) is characterised by a very weak intensity emission band at 520 nm (Φf = 0.0018, see ESI†) when excited at 488 nm. The weakly fluorescent nature of 1 has been ascribed to the PET from the crown unit to the BODIPY core.13e The electronic absorption spectrum of 1 (1 × 10−5 M, in CH3CN) exhibits an intense absorption band at 484 nm and a shoulder at 538 nm, attributed to internal charge-transfer (ICT) transition, responsible for the pink color of 1 (Fig. S1, see ESI†). Upon addition of aqueous solution of Hg2+ ions (2.87 × 10−7 M to 1.14 × 10−5 M) to a solution of 1 (5 × 10−6 M) saturation in the fluorescence intensity was achieved upon adding 1.11 × 10−5 M of Hg2+ (Fig. S1, see ESI†). While a similar saturation in the absorbance was achieved when Hg2+ solution was added to a concentration of 2.22 × 10−5 M (Fig. S2, see ESI†). Upon above addition of Hg2+, considerably enhanced intensity of the emission band (Φf = 0.2595, see ESI†) consequent to the interaction of Hg2+ with the crown unit receptor of 1, and a bathochromic shift in the intense absorption band, accompanied by a naked-eye color change, were observed. The analysis of the titration data and theoretical calculations were suggestive of a 1
:
1 stoichiometry of the most stable 1:Hg2+ species 2 with binding constant value log
β1,1 = 4.55. Further, 2 showed excellent selectivity for cys over other amino acids such as L-alanine, L-arginine, L-aspartic acid, L-glutamic acid, L-histidine, L-proline, L-leucine, L-isoleucine, L-lysine, L-methionine, L-ornithine, L-phenylalanine, L-proline, L-serine, L-threonine and L-valine (Fig. 1).
 |
| Fig. 1 Changes in the emission spectra of 2 (1.64 × 10−5 M, in CH3CN, red) upon addition of different amino acids (2.85 × 10−6 M, in water, blue). | |
On successive addition of an aqueous solution of cys (2.85 × 10−7 M to 2.85 × 10−6 M, in water) to a solution of 2 (1.64 × 10−5 M, in CH3CN), the intensity of the emission band of 2 at 520 nm decreases regularly and gets stabilised when addition of 2.57 × 10−6 M solution is achieved (Fig. 2). This has been attributed to the reversed PET consequent to obvious snatching of Hg2+ ions by the cys, as shown in Scheme 1, causing the fluorescence spectra of 2 to match gradually with that of 1 (Φf = 0.0027, see ESI†) releasing the complex 3 in solution with binding constant log
β = 6.33 (for detail see ESI†). Such a reversal event was also observed in the absorption spectrum of 2, wherein upon gradual addition of a solution of cys (2.85 × 10−7 to 4.28 × 10−6 M, in H2O), a hypsochromic shift of the intense absorption band at 498 nm to 484 nm as well as the appearance of the shoulder resulted along with a naked-eye color change from light orange to pink (Fig. 3). This absorbance change reached the saturation point at the addition of 4 × 10−6 M solution of cys. The release of 1 from 2 and the formation of 3 resulted from the snatching of Hg2+ by cys, was further confirmed from the high resolution mass spectrum (HRMS) which shows a peak at m/z 443.0, corresponding to [Hg2+ + 2cys − H]+ (Fig. 4a). From the 1H NMR spectral data (Fig. 4b, for detail see ESI†) we could notice that the resulting chemical shifts of 1 in the presence of Hg2+ return to the original values upon the addition of cys. The calculated detection limit of 1.60 × 10−8 M is significantly lower than most of the probes reported in the literature (Table S2, see ESI†). In order to ascertain the thiol selectivity of 2, and to rule out the interference from the other amino acids without thiol groups, listed above, competitive experiments were performed. No notable change was observed, which is a significant consideration from practical applications point of view (Fig. 5).
 |
| Fig. 2 Changes in the emission spectra of 2 (1.64 × 10−5 M, in CH3CN), on addition of different concentrations of cys (2.85 × 10−7 M to 2.85 × 10−6 M, in water) in CH3CN. | |
 |
| Fig. 3 Changes in the absorption spectra of 2 (3.28 × 10−5 M, in CH3CN) on addition of different concentration of cysteine (2.85 × 10−7 to 4.28 × 10−6 M, in H2O), in CH3CN. | |
 |
| Fig. 4 (a) HRMS spectrum of 2 after addition of cys (b) 1H NMR spectra of 1, 2 and 2 + cys showing shift in signal positions. | |
 |
| Fig. 5 Changes in the emission intensity (1) of 2 (1.64 × 10−5 M, in CH3CN) upon addition of (2) cys (2.85 × 10−6 M, in water) (3) other amino acids (2.85 × 10−6 M, in water) (4) cys in the presence of other amino acids. | |
Interestingly, the reversible interconversion of 1/2/3 could be repeated successfully by the addition of constant amounts of cys and Hg2+ to the solution of 2 suggesting 2 to be a suitable candidate for the on–off probe for cys (Fig. 6). Moreover, the combined fluorescent behaviour of 1/2/cys could be applied for the reversible and reproducible chemical switching represented via a molecular “INHIBIT” logic gate, employing Hg2+ and cys as two inputs and emission of 1 at 520 nm as the output, for which the truth table and symbol are shown in Fig. 7. In the truth table, the characters 0 and 1 indicate off and on states, respectively. The INHIBIT logic gates find applications in the subtractors, comparators and multiplexer logic circuits with the processing capabilities.15
 |
| Fig. 6 Fluorescence intensity of 2 (1.64 × 10−5 M) upon alternate addition of cys and Hg2+ respectively: cys : Hg2+ in (a) 0 : 11.4 μM (b) 2.85 : 11.4 μM (c) 2.85 : 22.8 μM (d) 5.7 : 22.8 μM (e) 5.7 : 34.2 μM (f) 8.55 : 34.2 μM (g) 8.55 : 45.6 μM (h) 11.4 : 45.6 μM, and the corresponding color changes. | |
 |
| Fig. 7 (a) Truth table (b) symbol for the INHIBIT logic gate. | |
Further, the coordination based selectivity of 1 for Hg2+ in solution, as discussed above, prompted us to mimic the sensing event in soft material (hydrogels). Thus, doping of the sodium cholate with various metal ions led to the corresponding cholate hydrogels (Fig. 8).16 When the doped hydrogels were exposed to the solution of 1 at room temperature, only the gel network of the Hg2+ doped hydrogel collapsed entirely to result in fluorescent coloured sol phase (Fig. 8). On the basis of this observation, we propose that 1 can be used for detecting Hg2+ in the soft materials and can also offer itself for possible decontamination of Hg2+ contaminated soft materials based on metal cholate hydrogels (a chemical decontamination method). While adding solution of cys to the hydrogel containing 1 and Hg2+, the fluorescence of the Hg2+ doped sol disappeared to replicate the colour changes depicted in Fig. 6, leading to qualitative sensing of cys in the hydrogel.
 |
| Fig. 8 Photographs of the metal cholate hydrogels before and after treatment with 1 under UV light and after addition of cys in the sol Hg2+ + 1. | |
Conclusions
In summary, the in situ formed BODIPY dye:Hg2+ complex detects cys over other non-thiol amino acids. The reversible sensing event involving decomplexation/complexation has been supported by various spectroscopic data. Additionally, the possible use of the crown–BODIPY dyad to detect Hg2+ as well as cys from the soft materials operating via gel–sol conversion has been demonstrated.
Acknowledgements
The authors thank CSIR, New Delhi (Project: 01/2687/12-EMR-II). NK thanks DST, New Delhi for an INSPIRE fellowship.
Notes and references
-
(a) S. Shahrokhian, Anal. Chem., 2001, 73, 5972–5978 CrossRef CAS;
(b) S. Seshadri, A. Beiser, J. Selhub, P. F. Jacques, I. H. Rosenberg, R. B. D Agostino, P. W. Wilson and P. A. Wolf, N. Engl. J. Med., 2002, 346, 476–483 CrossRef CAS PubMed;
(c) P. M. Veland and S. E. Vollset, Clin. Chem., 2004, 50, 1293–1295 CrossRef PubMed;
(d) R. Hong, G. Han, J. M. Fernandez, B.-J. Kim, N. S. Forbes and V. M. Rotello, J. Am. Chem. Soc., 2006, 128, 1078–1079 CrossRef CAS PubMed.
- V. Gazit, R. Ben-Abraham, R. Coleman, A. Weizman and Y. Katz, Amino Acids, 2004, 26, 163–168 CrossRef CAS PubMed.
-
(a) W. Hao, A. McBride, S. McBride, J. P. Gao and Z. Y. Wang, J. Mater. Chem., 2011, 21, 1040–1048 RSC;
(b) H. Xu, Y. Wang, X. Huang, Y. Li, H. Zhang and X. Zhong, Analyst, 2012, 137, 924–931 RSC;
(c) H. Su, F. Qiao, R. Duan, L. Chen and S. Ai, Biosens. Bioelectron., 2013, 43, 268–273 CrossRef CAS PubMed;
(d) J. Wu, R. Sheng, W. Liu, P. Wang, J. Ma, H. Zhang and X. Zhuang, Inorg. Chem., 2011, 50, 6543–6551 CrossRef CAS PubMed.
- P. Capitan, T. Malmezat, D. Breuille and C. Obled, J. Chromatogr. B: Biomed. Sci. Appl., 1999, 732, 127–135 CrossRef CAS.
- Y. Hiraku, M. Murata and S. Kawanishi, Biochim. Biophys. Acta, 2002, 1570, 47–52 CrossRef CAS.
- X. Guan, B. Hoffman, C. Dwivedi and D. P. Mathees, J. Pharm. Biomed. Anal., 2003, 31, 251–261 CrossRef CAS.
-
(a) M. Y. Berezin and S. Achilefu, Chem. Rev., 2010, 110, 2641–2684 CrossRef CAS PubMed;
(b) J. H. Lee, C. S. Lim, Y. S. Tian, J. H. Han and B. R. Cho, J. Am. Chem. Soc., 2010, 132, 1216–1217 CrossRef CAS PubMed.
-
(a) F. J. Huo, Y. Q. Sun, J. Su, J. B. Chao, H. J. Zhi and C. X. Yin, Org. Lett., 2009, 11, 4918–4921 CrossRef CAS PubMed;
(b) F. J. Huo, Y. Q. Sun, J. Su, Y. T. Yang, C. X. Yin and J. B. Chao, Org. Lett., 2010, 12, 4756–4759 CrossRef CAS PubMed;
(c) V. Hong, A. A. Kislukhin and M. G. Finn, J. Am. Chem. Soc., 2009, 131, 9986–9994 CrossRef CAS PubMed;
(d) S. Sreejith, K. P. Divya and A. Ajayaghosh, Angew. Chem., Int. Ed., 2008, 47, 7883–7887 CrossRef CAS PubMed.
-
(a) W. Y. Lin, L. L. Long, L. Yuan, Z. M. Cao, B. B. Chen and W. Tan, Org. Lett., 2008, 10, 5570–5580 Search PubMed;
(b) K. S. Lee, T. K. Kim, J. H. Lee, H. J. Kim and J. I. Hong, Chem. Commun., 2008, 6173–6175 RSC;
(c) H. L. Li, J. L. Fan, J. Y. Wang, M. Z. Tian, J. J. Du, S. G. Sun, P. P. Sun and X. J. Peng, Chem. Commun., 2009, 5904–5906 RSC.
-
(a) M. M. Pires and J. Chmielewski, Org. Lett., 2008, 10, 837–840 CrossRef CAS PubMed;
(b) J. H. Lee, C. S. Lim, Y. S. Tian, J. H. Han and B. R. Cho, J. Am. Chem. Soc., 2010, 132, 1216–1217 CrossRef CAS PubMed.
-
(a) M. A. Hortala, L. Fabbrizzi, N. Marcotte, F. Stomeo and A. Taglietti, J. Am. Chem. Soc., 2003, 125, 20–21 CrossRef CAS PubMed;
(b) S. Li, C. Yu and J. Xu, Chem. Commun., 2005, 450–452 RSC;
(c) Y. Fu, H. Li, W. Hu and D. Zhu, Chem. Commun., 2005, 3189–3191 RSC.
- W. Wang, J. O. Escobedo, C. M. Lawrence and R. M. Strongin, J. Am. Chem. Soc., 2004, 126, 3400–3401 CrossRef CAS PubMed.
-
(a) P. Kaur, M. Kaur, V. Dhuna, S. Singh and K. Singh, Dalton Trans., 2014, 43, 5707–5712 RSC;
(b) P. Kaur, D. Sareen and K. Singh, Anal. Chim. Acta, 2013, 778, 79–86 CrossRef CAS PubMed;
(c) P. Kaur, H. Kaur and K. Singh, Analyst, 2013, 138, 425–428 RSC;
(d) P. Kaur, D. Sareen and K. Singh, Dalton Trans., 2012, 41, 9607–9610 RSC;
(e) P. Kaur, N. Kaur, M. Kaur, V. Dhuna, J. Singh and K. Singh, RSC Adv., 2014, 4, 16104–16108 RSC.
-
(a) F. Miao, J. Zhan, Z. Zou, D. Tian and H. Li, Tetrahedron, 2012, 68, 2409–2413 CrossRef CAS PubMed;
(b) Y. B. Ruan, A. F. Li, J. S. Zhao, J. S. Shen and Y. B. Jiang, Chem. Commun., 2010, 46, 4939–4940 Search PubMed;
(c) L. Xu, Y. Xu, W. Zhu, B. Zeng, C. Yang, B. Wu and X. Qian, Org. Biomol. Chem., 2011, 9, 8284–8287 RSC;
(d) C. Luo, Q. Zhou, B. Zhang and X. Wang, New J. Chem., 2011, 35, 45–48 RSC;
(e) X. Lou, L. Zhang, J. Qin and Z. Li, Langmuir, 2010, 26, 1566–1569 CrossRef CAS PubMed;
(f) A. Pal and B. Bag, RSC Adv., 2014, 4, 10118–10122 RSC.
-
(a) U. Pischel, Angew. Chem., Int. Ed., 2007, 46, 4026–4040 CrossRef CAS PubMed;
(b) A. Coskun, E. Deniz and E. U. Akkaya, Org. Lett., 2005, 7, 5187–5189 CrossRef CAS PubMed;
(c) D. Margulies, G. Melman and A. Shanzer, J. Am. Chem. Soc., 2006, 128, 4865–4871 CrossRef CAS PubMed;
(d) J. Andreasson, S. D. Straight, S. Bandyopadhyay, R. H. Mitchell, T. A. Moore, A. L. Moore and D. Gust, Angew. Chem., Int. Ed., 2007, 46, 958–961 CrossRef CAS PubMed;
(e) U. Pischel and B. Heller, New J. Chem., 2008, 32, 395–400 RSC;
(f) M. Kluciar, R. Ferreira, B. D. Castro and U. Pischel, J. Org. Chem., 2008, 73, 6079–6085 CrossRef CAS PubMed.
- A. Chakrabarty, U. Maitra and A. Devi Das, J. Mater. Chem., 2012, 22, 18268–18274 RSC.
Footnote |
† Electronic supplementary information (ESI) available: Additional absorption, emission, spectral and Gaussian data. See DOI: 10.1039/c4ra04486j |
|
This journal is © The Royal Society of Chemistry 2014 |
Click here to see how this site uses Cookies. View our privacy policy here.